Alpha-fetoprotein as a factor of differentiation and functional activity of myeloid-derived suppressor cells
KY Shardina, SA Zamorina, VP Timganova… - Bulletin of Experimental …, 2023 - Springer
We studied the role of alpha-fetoprotein (AFP) in regulation of differentiation and functional
activity of human myeloid-derived suppressor cells (MDSC) in vitro. To obtain MDSC …
activity of human myeloid-derived suppressor cells (MDSC) in vitro. To obtain MDSC …
[PDF][PDF] A Cancer Prevention and Treatment Opportunity
VN Pak - Glob J Med Res: F Dis, 2023 - researchgate.net
Cancer disease results from mutations leading to apoptosis failure and immune system
dysfunction. Because one in two people in developed counties will be diagnosed with …
dysfunction. Because one in two people in developed counties will be diagnosed with …
[HTML][HTML] Alpha-Fetoprotein: A Revolutionary Anti-Cancer Drug
VN Pak - Medical Research Archives, 2023 - esmed.org
Alpha-fetoprotein is an oncofetal protein the embryo produces during fetal development. The
protein serves two critical functions simultaneously: it delivers nutrients to growing embryo …
protein serves two critical functions simultaneously: it delivers nutrients to growing embryo …
Alpha-Fetoprotein Binds Toxins and Can Be Used to Treat Cancer
VN Pak - Medical Research Archives, 2022 - esmed.org
The inefficiency of the immune system to kill cancer cells leads to the disease. Like in
pregnancy, oncofetal proteins counteract the immune attack. Alpha-fetoprotein is an …
pregnancy, oncofetal proteins counteract the immune attack. Alpha-fetoprotein is an …
GRAPHENE OXIDE AS A NOVEL IMMUNOTHERAPY TOOL FOR THE MODULATION OF MYELOID-DERIVED SUPPRESSOR CELL ACTIVITY IN THE CONTEXT OF …
C Camacho-Toledano, I Machín-Díaz, R Lebrón-Galán… - bioRxiv, 2023 - biorxiv.org
Multiple Sclerosis (MS) is a chronic, inflammatory disease of the central nervous system.
Despite the pharmacological arsenal approved for MS, there are treatment-reluctant patients …
Despite the pharmacological arsenal approved for MS, there are treatment-reluctant patients …